合成路线1
该中间体在本合成路线中的序号:
(XI) Three related new synthetic routes for E-1020 have been reported:
1) The cyclization of 2-bromoacetaldehyde diethylacetal (I) with 2-aminopyridine-5-carboxylic acid methyl ester (II) by means of HCl in hot water gives imidazo[1,2-a]pyridine-6-carboxylic acid methyl ester (III), which is reduced with dibutylaluminum hydride in dichloromethane to the corresponding aldehyde (IV). The condensation of (IV) with nitroethane (V) by means of butylamine in refluxing ethanol affords 6-(2-nitro-1-propenyl)imidazo[1,2-a]pyridine (VI), which is treated with Fe-FeCl2-HCl in hot ethanol-water to give 1-(imidazo[1,2-a]pyridyl-6-yl)-2-propanone (VII). The condensation of (VII) with dimethylformamide dimethylacetal (VIII) in hot DMF yields 4-(dimethylamino)-3-(imidazo[1,2-a]pyridin-6-yl)-3-buten-2-one (IX), which is finally cyclized with cyanacetamide (X) by means of sodium methoxide in hot DMF.
2) The cyclization of acetal (I) with 2-amino-5-bromopyridine (XI) as before gives 6-bromoimidazo[1,2-a]pyridine (XII), which is condensed with potassium acetylacetonate (XIII) by means of KI and Cu2I2 in hot DMF yielding the adduct (XIV). The cleavage of (XIV) with NaOH and then with HCl gives the propanone (VII), already obtained.
3) The condensation of the bromo derivative (XII) with 3-chloro-2-methylpropene (XV) by means of ethylmagnesium bromide in hot THF gives 6-isobutenylimidazo[1,2-a]pyridine (XVI), which is ozonolyzed with O3 in methanol-water-HCl to yield the propanone (VII), already obtained.
【1】
Yamanaka, M.; Miyake, K.; Suda, S.; Ohhara, H.; Ogawa, T.; Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives. Chem Pharm Bull 1991, 39, 6, 1556-67.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12113 |
2-Bromo-1-ethoxyethyl ethyl ether; 2-Bromo-1,1-diethoxyethane; Bromoacetaldehyde diethylacetal
|
2032-35-1 |
C6H13BrO2 |
详情 | 详情
|
(II) |
12114 |
methyl 6-aminonicotinate
|
|
C7H8N2O2 |
详情 |
详情
|
(III) |
12115 |
methyl imidazo[1,2-a]pyridine-6-carboxylate
|
|
C9H8N2O2 |
详情 |
详情
|
(IV) |
12116 |
Imidazo[1,2-a]pyridine-6-carbaldehyde
|
|
C8H6N2O |
详情 |
详情
|
(V) |
12117 |
Nitroethane; 1-Nitroethane
|
79-24-3 |
C2H5NO2 |
详情 | 详情
|
(VI) |
12118 |
6-[(E)-2-Nitro-1-propenyl]imidazo[1,2-a]pyridine
|
|
C10H9N3O2 |
详情 |
详情
|
(VII) |
12119 |
1-Imidazo[1,2-a]pyridin-6-ylacetone
|
|
C10H10N2O |
详情 |
详情
|
(VIII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(IX) |
12121 |
(Z)-4-(Dimethylamino)-3-imidazo[1,2-a]pyridin-6-yl-3-buten-2-one
|
|
C13H15N3O |
详情 |
详情
|
(X) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
(XI) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(XII) |
12124 |
6-Bromoimidazo[1,2-a]pyridine
|
6188-23-4 |
C7H5BrN2 |
详情 | 详情
|
(XIII) |
12125 |
[2-Methoxy-1-(methoxycarbonyl)-2-oxoethyl]potassium
|
|
C5H7KO4 |
详情 |
详情
|
(XIV) |
12126 |
3-Imidazo[1,2-a]pyridin-6-yl-2,4-pentanedione
|
|
C12H12N2O2 |
详情 |
详情
|
(XV) |
12127 |
3-Chloro-2-methyl-1-propene; Isobutenyl chloride
|
563-47-3 |
C4H7Cl |
详情 | 详情
|
(XVI) |
12128 |
6-(2-Methyl-2-propenyl)imidazo[1,2-a]pyridine
|
|
C11H12N2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) The acetylation of 5-bromopyridine-2-amine (I) with acetic anhydride in AcOH gives the expected amide (II), which is alkylated with ethylene by means of palladium acetate, tri p-tolylphosphine and triethylamine in hot acetonitrile to yield N-(5-vinylpyridin-2-yl)acetamide (III). The regioselective dihydroxylation of the vinyl group of (III) with AD-Mix-B in tert-butanol affords N-[5-(1(R),2-dihydroxyethyl)pyridin-2-yl]acetamide (IV), which is monotosylated with Ts-Cl in cool pyridine to give the tosylate (V). The reaction of (V) with potassium tert.-butoxide in THF yields the epoxide (VI), which is condensed with 2-[4-(2-aminoethoxy)phenyl]-N-methylacetamide (VII) in hot toluene/DMSO to provide the expected addition product (VIII). Finally, this compound is treated with 6N HCl on a steam bath.
The intermediate 2-[4-(2-aminoethoxy)phenyl]-N-methylacetamide (VII) has been obtained as follows: The reaction of benzyl chloroformate (IX) with ethanolamine (X) by means of NaHCO3 in water gives the carbamate (XI), which is condensed with 2-(4-hydroxyphenyl)-N-methylacetamide (XII) (obtained by reaction of the corresponding methyl ester (XIII) with methylamine), by means of PPh3 and diisopropyl azodicarboxylate (DIAD) in THF yielding the intermediate (XIV). Finally, this compound is submitted to elimination of the carbamate protecting group by hydrogenation with H2 over Pd/C in methanol to provide the target intermediate (VII).
【1】
Dow, R.L. (Pfizer Inc.); beta-Adrenergic agonists to reduce a wasting condition. EP 0887079 .
|
【2】
Devries, K.M.; Dow, R.L.; Wright, S.W. (Pfizer Inc.); Process for substd. pyridines. EP 0938476; WO 9821184 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
32490 |
N-(5-bromo-2-pyridinyl)acetamide
|
|
C7H7BrN2O |
详情 |
详情
|
(III) |
32491 |
N-(5-vinyl-2-pyridinyl)acetamide
|
|
C9H10N2O |
详情 |
详情
|
(IV) |
32492 |
N-[5-[(1R)-1,2-dihydroxyethyl]-2-pyridinyl]acetamide
|
|
C9H12N2O3 |
详情 |
详情
|
(V) |
32493 |
(2R)-2-[6-(acetamido)-3-pyridinyl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C16H18N2O5S |
详情 |
详情
|
(VI) |
32494 |
N-[5-[(2R)oxiranyl]-2-pyridinyl]acetamide
|
|
C9H10N2O2 |
详情 |
详情
|
(VII) |
32495 |
2-[4-(2-aminoethoxy)phenyl]-N-methylacetamide
|
|
C11H16N2O2 |
详情 |
详情
|
(VIII) |
32496 |
2-[4-[2-([(2R)-2-[6-(acetamido)-3-pyridinyl]-2-hydroxyethyl]amino)ethoxy]phenyl]-N-methylacetamide
|
|
C20H26N4O4 |
详情 |
详情
|
(IX) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(X) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(XI) |
32497 |
benzyl 2-hydroxyethylcarbamate
|
77987-49-6 |
C10H13NO3 |
详情 | 详情
|
(XII) |
32498 |
2-(4-hydroxyphenyl)-N-methylacetamide
|
|
C9H11NO2 |
详情 |
详情
|
(XIII) |
15822 |
Methyl 4-hydroxyphenylacetate; methyl 2-(4-hydroxyphenyl)acetate
|
14199-15-6 |
C9H10O3 |
详情 | 详情
|
(XIV) |
32499 |
benzyl 2-[4-[2-(methylamino)-2-oxoethyl]phenoxy]ethylcarbamate
|
|
C19H22N2O4 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) Condensation of 2-amino-5-bromopyridine (I) with 1,1-thiocarbonyl diimidazole (II) furnished the thiocarbonyl derivative (III). Further reaction of (III) with 1-(2-aminoethyl)piperidine (IV) gave the target thiourea.
【1】
Mao, C.; Vig, R.; Venkatachalam, T.K.; Sudbeck, E.A.; Uckun, F.M.; Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 1998, 8, 16, 2213. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
24646 |
2-(1-piperidinyl)-1-ethanamine
|
27578-60-5 |
C7H16N2 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) Condensation of 2-amino-5-bromopyridine (I) with 1,1-thiocarbonyl diimidazole (II) furnished the thiocarbonyl derivative (III). Further reaction of (III) with 1-(2-aminoethyl)piperazine (IV) gave the target thiourea.
【1】
Mao, C.; Vig, R.; Venkatachalam, T.K.; Sudbeck, E.A.; Uckun, F.M.; Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 1998, 8, 16, 2213. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
24647 |
2-(1-piperazinyl)-1-ethanamine
|
140-31-8 |
C6H15N3 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 2-chlorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31334 |
2-chlorophenethylamine; 2-(2-chlorophenyl)-1-ethanamine
|
13078-80-3 |
C8H10ClN |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 3-chlorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31335 |
3-chlorophenethylamine; 2-(3-chlorophenyl)-1-ethanamine
|
13078-79-0 |
C8H10ClN |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 2-fluorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
【2】
Uckun, F.M. (Parker Hughes Institute); NNI for treatment of multi-drug resistant HIV. WO 0056736 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31333 |
2-fluorophenethylamine; 2-(2-fluorophenyl)-1-ethanamine
|
|
C8H10FN |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The reaction of 5-bromopyridin-2-amine (I) with thiocarbonyldiimidazole (II) in acetonitrile gives the thioamide (III), which is finally condensed with 2-(2,5-dimethoxyphenyl)ethylamine (IV) in DMF at 100 C.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
【2】
Uckun, F.M. (Parker Hughes Institute); NNI for treatment of multi-drug resistant HIV. WO 0056736 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
36889 |
2,5-dimethoxyphenethylamine; 2-(2,5-dimethoxyphenyl)-1-ethanamine
|
3600-86-0 |
C10H15NO2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) 2-Amino-5-bromopyridine (I) was condensed with 1,1-thiocarbonyldiimidazole (II) in acetonitrile to furnish the precursor thiocarbonyl derivative (III). Further reaction of (III) with 3-fluorophenethylamine (IV) in DMF at 100 C gave the target thiourea.
【1】
Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M.; Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg Med Chem 1998, 6, 10, 1789. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(IV) |
31336 |
3-fluorophenethylamine; 2-(3-fluorophenyl)-1-ethanamine
|
|
C8H10FN |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(XIII) 3-Fluorophenol (I) was converted into propionic ester (II) by treatment with propionyl chloride and pyridine. Fries rearrangement of (II) in the presence of AlCl3 furnished propiophenone (III). The phenolic hydroxyl group of (III) was then protected as the methyl ether (IV) using iodomethane and K2CO3. The keto group of (IV) was subsequently protected as the ethylene ketal (V) by treatment with ethylene glycol and p-toluenesulfonic acid. Lithiation of (V) with n-butyllithium in THF at -65 C, followed by formylation with N,N-dimethylformamide yielded aldehyde (VI). Styrene derivative (VII) was obtained by Wittig reaction of aldehyde (VI) with methylene triphenylphosphorane. Asymmetric cyclopropanation of (VII) with ethyl diazoacetate in the presence of cuprous triflate and the chiral auxiliary (VIII) gave the desired (1S,2R)-cis ester (IX) along with some trans isomer, that was separated by column chromatography. After ketal (IX) hydrolysis with HCl, the resulting keto ester (X) was saponified with LiOH to provide cyclopropanecarboxylic acid (XI). Curtius rearrangement of acid (XI) employing diphenylphosphoryl azide produced isocyanate (XII), which was subsequently condensed with 2-amino-5-bromopyridine (XIII) to afford urea (XIV). The methyl ether group of (XIV) was finally cleaved to the title phenol by means of boron trichloride in CH2Cl2.
【1】
Sahlberg, C.; Engelhardt, P.; Hogberg, M.; et al.; Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors.3.Synthesis and further structure-activity relationship studies of PETT analogues. J Med Chem 1999, 42, 20, 4150.
|
【2】
Noreen, R.; Hogberg, M.; Engelhardt, P.; Sahlberg, C. (Medivir AB); Antivirals. WO 9936406 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23809 |
3-fluorophenol
|
372-20-3 |
C6H5FO |
详情 | 详情
|
(II) |
41992 |
3-fluorophenyl propionate
|
|
C9H9FO2 |
详情 |
详情
|
(III) |
41993 |
1-(4-fluoro-2-hydroxyphenyl)-1-propanone
|
|
C9H9FO2 |
详情 |
详情
|
(IV) |
41994 |
1-(4-fluoro-2-methoxyphenyl)-1-propanone
|
|
C10H11FO2 |
详情 |
详情
|
(V) |
41995 |
2-ethyl-2-(4-fluoro-2-methoxyphenyl)-1,3-dioxolane; 2-(2-ethyl-1,3-dioxolan-2-yl)-5-fluorophenyl methyl ether
|
|
C12H15FO3 |
详情 |
详情
|
(VI) |
41996 |
3-(2-ethyl-1,3-dioxolan-2-yl)-6-fluoro-2-methoxybenzaldehyde
|
|
C13H15FO4 |
详情 |
详情
|
(VII) |
41997 |
6-(2-ethyl-1,3-dioxolan-2-yl)-3-fluoro-2-vinylphenyl methyl ether; 2-ethyl-2-(4-fluoro-2-methoxy-3-vinylphenyl)-1,3-dioxolane
|
|
C14H17FO3 |
详情 |
详情
|
(VIII) |
41998 |
(4R)-4-(tert-butyl)-2-[1-[(4R)-4-(tert-butyl)-4,5-dihydro-1,3-oxazol-2-yl]-1-methylethyl]-4,5-dihydro-1,3-oxazole
|
|
C17H30N2O2 |
详情 |
详情
|
(IX) |
41999 |
ethyl (1S,2R)-2-[3-(2-ethyl-1,3-dioxolan-2-yl)-6-fluoro-2-methoxyphenyl]cyclopropanecarboxylate
|
|
C18H23FO5 |
详情 |
详情
|
(X) |
42000 |
ethyl (1S,2R)-2-(6-fluoro-2-methoxy-3-propionylphenyl)cyclopropanecarboxylate
|
|
C16H19FO4 |
详情 |
详情
|
(XI) |
42001 |
(1S,2R)-2-(6-fluoro-2-methoxy-3-propionylphenyl)cyclopropanecarboxylic acid
|
|
C14H15FO4 |
详情 |
详情
|
(XII) |
42002 |
1-[4-fluoro-3-[(1S,2S)-2-isocyanatocyclopropyl]-2-methoxyphenyl]-1-propanone
|
|
C14H14FNO3 |
详情 |
详情
|
(XIII) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(XIV) |
42003 |
N-(5-bromo-2-pyridinyl)-N'-[(1S,2S)-2-(6-fluoro-2-methoxy-3-propionylphenyl)cyclopropyl]urea
|
|
C19H19BrFN3O3 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) Treatment of 2-amino-5-bromopyridine (I) with 2-(1-cyclohexenyl)ethyl isothiocyanate (II) in hot N-methylpyrrolidinone produced the target thiourea.
【1】
Lind, P.T.; Noreen, R.; Ternansky, R.J.; Morin, J.M. Jr. (Medivir AB); Cpds. and methods for inhibition of HIV and related viruses. WO 9303022 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
36901 |
2-(1-cyclohexen-1-yl)ethyl isothiocyanate; 1-(2-isothiocyanatoethyl)-1-cyclohexene
|
|
C9H13NS |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(I) Alternatively, 2-amino-5-bromopyridine (I) was reacted with 1,1'-thiocarbonyldiimidazole (III) in acetonitrile yielding thioimidazolide (IV), which was then condensed with 2-(1-cyclohexenyl)ethylamine (V) in hot DMF.
【1】
Maher, D.; Mao, C.; Pendergrass, S.; Venkatachalam, T.K.; Zhu, D.; Tuel-Ahlgren, L.; Uckun, F.M.; N-[2-(1-Cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1. Bioorg Med Chem Lett 1999, 9, 18, 2721. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(III) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(IV) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(V) |
36902 |
2-(1-cyclohexen-1-yl)ethylamine; 2-(1-cyclohexen-1-yl)-1-ethanamine; 2-(1-Cyclohexenyl)ethylamine
|
3399-73-3 |
C8H15N |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(I) Reaction of 2-amino-5-bromopyridine (I) with thiocarbonyl diimidazole (II) provided the thioimidazolide (III). This was then coupled with 2-(2-thienyl)ethyl amine (IV) to furnish the target thiourea.
【1】
Maher, D.; Mao, C.; Tuel-Ahlgren, L.; Uckun, F.M.; Zhu, D.; Pendergrass, S.; Venkatachalam, T.K.; N'-[2-(2-Thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1. Bioorg Med Chem Lett 1999, 9, 24, 3411. |
【2】
Ventatachalam, T.K.; Uckun, F.M. (Parker Hughes Institute); Thiophene-ethyl thiourea cpds. and use. US 6124324; WO 0078755 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
35253 |
2-(2-thienyl)ethylamine; 2-(2-thienyl)-1-ethanamine; 2-Thiophene ethylamine
|
30433-91-1 |
C6H9NS |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(I) Reaction of 2-amino-5-bromopyridine (I) with thiocarbonyldiimidazole (II) afforded the thioimidazolide (III). This was then condensed with 4-methylphenetylamine (IV) in hot DMF to produce the required thiourea.
【2】
Ventalachalam, T.K.; Uckum, F.M. (Parker Hughes Institute); Phenethyl-thiourea cpds. and use. US 6207688 .
|
【1】
Uckun, F.M.; Zhu, D.; Pendergrass, S.; Mao, C.; Tuel-Ahlgren, L.; Venkatachalam, T.K.; Maher, D.; N-[2-(4-Methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1. Antivir Chem Chemother 2000, 11, 2, 135. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
46291 |
4-methylphenethylamine; 2-(4-methylphenyl)-1-ethanamine
|
|
C9H13N |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(I) Condensation of 2-amino-5-bromopyridine (I) with thiocarbonyl diimidazole (II) gave rise to thioimidazolide (III), which was then condensed with (R)-1-phenylethylamine (IV) to yield the title thiourea.
【1】
Mao, C.; Venkatachalam, T.K.; Uckun, F.M.; Sudbeck, E.A.; Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 2000, 10, 18, 2071. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(II) |
11990 |
Di(1H-imidazol-1-yl)methanethione; 1,1'-Thiocarbonyldiimidazole
|
6160-65-2 |
C7H6N4S |
详情 | 详情
|
(III) |
24645 |
N-(5-bromo-2-pyridinyl)-1H-imidazole-1-carbothioamide
|
|
C9H7BrN4S |
详情 |
详情
|
(IV) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) Condensation between 2-bromo-4'-(dimethylamino)acetophenone (I) and 2-amino-5-bromopyridine (II) gives rise to the imidazopyridine (III). Subsequent palladium-catalyzed stannylation of (III) affords the tributyltin derivative (IV). The target radio-iodinated compound is then obtained by iododstannylation of (IV) with [125I] iodide in the presence of H2O2 (1,2)
【1】
Zhuang, Z.-P.; Kung, M.-P.; Wilson, A.; Lee, C.-W.; Plossl, K.; Hou, C.; Holtzman, D.M.; Kung, H.F.; Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain. J Med Chem 2003, 46, 2, 237.
|
【2】
Kung, H.; Kung, M.-P.; Zhuang, Z.-P. (University of Pennsylvania); Amyloid plaque aggregation inhibitors and diagnostic imaging agents. CA 2444214; EP 1381604; US 2003059369; WO 0285903 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63545 |
2-bromo-1-[4-(dimethylamino)phenyl]-1-ethanone
|
|
C10H12BrNO |
详情 |
详情
|
(II) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(III) |
63546 |
4-(6-bromoimidazo[1,2-a]pyridin-2-yl)-N,N-dimethylaniline; N-[4-(6-bromoimidazo[1,2-a]pyridin-2-yl)phenyl]-N,N-dimethylamine
|
|
C15H14BrN3 |
详情 |
详情
|
(IV) |
63547 |
N,N-dimethyl-4-[6-(tributylstannyl)imidazo[1,2-a]pyridin-2-yl]aniline; N,N-dimethyl-N-{4-[6-(tributylstannyl)imidazo[1,2-a]pyridin-2-yl]phenyl}amine
|
|
C27H41N3Sn |
详情 |
详情
|